Information

Home Information
  • Jan 10, 2025

Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?

On Friday, Mersana Therapeutics Inc. (NASDAQ:MRSN) released initial data from the Phase 1 dose escalation and backfill cohorts for emiltatug ledadotin. Emi-Le was generally well tolerated, with no Grade 4 or 5 treatment-related adverse events reported. At intermediate doses in the trial (38.1 mg/m2 to 67.4 mg/m2), the confirmed objective response rate among evaluable patients was 23% (6 of 26 patients) across all B7-H4 high tumors and 23% (3 of 13 patients) with B7-H4 high TNBC, all of whom had

  • Jan 10, 2025

BofA bets on a potential Fed rate hike after jobs report, top Wall-St brokers revise forecasts

Top Wall-Street brokerages revised their Fed rate cut forecasts, after a blow-out U.S. jobs report on Friday, with BofA Global Research forecasting a potential rate hike from the central bank. Data on Friday showed, Nonfarm payrolls increased by 256,000 jobs last month, the most since March, and data for October and November was revised to show 8,000 fewer jobs added than previously reported. Market participants see a 76.31% probability that the Fed will cut rates by 25 basis points in June, according to CME FedWatch tool.

  • Jan 10, 2025

What's Going On With COVID-19 Antibody Developer Invivyd Stock On Friday?

On Friday, Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda (pemivibart) and pipeline candidate VYD2311 against dominant SARS-CoV-2 variant XEC. The stock is trading with a strong session volume of 12.3 million, compared to an average volume of 757.02k as per data from Benzinga Pro. As anticipated, the data are largely consistent with those previously reported for KP.3.1.1, based on the structural biology of pemivibart an

  • Jan 10, 2025

UK Markets Cap Dire Week With Yields Stuck Near Decade Highs

(Bloomberg) -- A hectic week for UK bond and currency traders came to an end with yields stuck near the highest levels in years and the pound at its weakest since late 2023.Most Read from BloombergWhat Robotaxis Brought San FranciscoA Blueprint for Better Bike LanesNYC Condo Owners May Bear Costs of Landmark Green Building LawAmbitious High-Speed Rail Plans Advance in the Baltic RegionNYC’s Subway Violence Deters Drive to Bring Workers Back to OfficeGilts and sterling fell again on Friday after

  • Jan 10, 2025

Wall Street Economists Pare Back Fed Rate-Cut Views After Data

(Bloomberg) -- Economists at Bank of America Corp., Citigroup Inc. and Goldman Sachs Group Inc. pared back their forecasts for additional Federal Reserve interest-rate cuts in response to stronger-than-expected December US employment data released Friday.Most Read from BloombergWhat Robotaxis Brought San FranciscoA Blueprint for Better Bike LanesNYC Condo Owners May Bear Costs of Landmark Green Building LawAmbitious High-Speed Rail Plans Advance in the Baltic RegionNYC’s Subway Violence Deters D

Popular Post